Drug-eluting medical device
    1.
    发明授权

    公开(公告)号:US10029032B2

    公开(公告)日:2018-07-24

    申请号:US15440960

    申请日:2017-02-23

    IPC分类号: A61L29/16 A61M25/10 A61L29/06

    摘要: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.

    DRUG-ELUTING MEDICAL DEVICE
    3.
    发明申请

    公开(公告)号:US20200215234A1

    公开(公告)日:2020-07-09

    申请号:US16824138

    申请日:2020-03-19

    IPC分类号: A61L29/16 A61L29/06 A61M25/10

    摘要: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.

    DRUG-ELUTING MEDICAL DEVICE
    4.
    发明申请

    公开(公告)号:US20190015562A1

    公开(公告)日:2019-01-17

    申请号:US16042598

    申请日:2018-07-23

    IPC分类号: A61L29/16 A61M25/10 A61L29/06

    摘要: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.

    Drug-eluting medical device
    7.
    发明授权

    公开(公告)号:US10596303B2

    公开(公告)日:2020-03-24

    申请号:US16042598

    申请日:2018-07-23

    IPC分类号: A61L29/16 A61L29/06 A61M25/10

    摘要: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.